Ability of Plasmodium falciparum to invade Southeast Asian ovalocytes varies between parasite lines

Blood

Volumn 104, Issue 9, 2004, Pages 2961-2966

  Cortés, Alfred ^a   Benet, Ariadna ^b   Cooke, Brian M ^b   Barnwell, John W ^b   Reeder, John C ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; BRAIN MALARIA; CONTROLLED STUDY; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SOUTHEAST ASIA;

EID: 7244231205     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-06-2136     Document Type: Article

References (47)

1. Dolan SA, Proctor JL, Ailing DW, Okubo Y, Wellems TE, Miller LH. Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol Biochem Parasitol. 1994;64:55-63.
2. Okoyeh JN, Pillai CR, Chitnis CE. Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A. Infect Immun. 1999;67:5784-5791.
3. Nagel RL, Roth EF Jr. Malaria and red cell genetic defects. Blood. 1989;74:1213-1221.
4. Jarolim P, Palek J, Amato D, et al. Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. Proc Natl Acad Sci USA. 1991;88:11022-11026.
5. Tanner MJ, Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol. 1993;30:34-57.
6. Chambers EJ, Bloomberg GB, Ring SM, Tanner MJ. Structural studies on the effects of the deletion in the red cell anion exchanger (band 3, AE1) associated with South East Asian ovalocytosis. J Mol Biol. 1999;385:1289-1307.
7. Kuma H, Abe Y, Askin D, et al. Molecular basis and functional consequences of the dominant effects of the mutant band 3 on the structure of normal band 3 in Southeast Asian ovalocytosis. Biochemistry. 2002;41:3311-3320.
8. Smythe JS, Spring FA, Gardner B, Parsons SF, Judson PA, Anstee DJ. Monoclonal antibodies recognizing epitopes on the extracellular face and intracellular N-terminus of the human erythrocyte anion transporter (band 3) and their application to the analysis of South East Asian ovalocytes. Blood. 1995;85:2929-2936.
9. Schofield AE, Reardon DM, Tanner MJ. Defective anion transport activity of the abnormal band 3 in hereditary ovalocytic red blood cells. Nature. 1992;355:836-838.
10. Mgone CS, Koki G, Paniu MM, et al. Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea. Trans R Soc Trop Med Hyg. 1996;90:228-231.
11. Che A, Cherry RJ, Bannister LH, Dluzewski AR. Aggregation of band 3 in hereditary ovalocytic red blood cell membranes: electron microscopy and protein rotational diffusion studies. J Cell Sci. 1993;105(Pt3);655-660.
12. Sarabia VE, Casey JR, Reithmeier RA. Molecular characterization of the band 3 protein from Southeast Asian ovalocytes. J Biol Chem. 1993;268:10676-10680.
13. Dluzewski AR, Nash GB, Wilson RJ, Reardon DM, Gratzer WB. Invasion of hereditary ovalocytes by Plasmodium falciparum in vitro and its relation to intracellular ATP concentration. Mol Biochem Parasitol. 1992;55:1-7.
14. Mohandas N, Lie-Injo LE, Friedman M, Mak JW. Rigid membranes of Malayan ovalocytes: a likely genetic barrier against malaria. Blood. 1984;63:1385-1392.
15. Saul A, Lamont G, Sawyer WH, Kidson C. Decreased membrane deformability in Melanesien ovalocytes from Papua New Guinea. J Cell Biol. 1984;98:1348-1354.
16. Booth PB, Serjeantson S, Woodfield DG, Amato D. Selective depression of blood group antigens associated with hereditary ovalocytosis among melanesians. Vox Sang. 1977;32:99-110.
17. Amato D, Booth PB. Hereditary ovalocytosis in Melanesians. P N G Med J. 1977;20:26-32.
18. Alien SJ, O'Donnell A, Alexander ND, et al. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. Am J Trop Med Hyg. 1999;60:1056-1060.
19. Genton B, al-Yaman F, Mgone CS, et al. Ovalocytosis and cerebral malaria. Nature. 1995;378:564-565.
20. Serjeantson S, Bryson K, Amato D, Babona D. Malaria and hereditary ovalocytosis. Hum Genet. 1977;37:161-167.
21. Cattani JA, Gibson FD, Alpers MP, Crane GG. Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea. Trans R Soc Trop Med Hyg. 1987;81:705-709.
22. Foo LC, Rekhraj V, Chiang GL, Mak JW. Ovalocytosis protects against severe malaria parasitemia in the Malayan aborigines. Am J Trop Med Hyg. 1992;47:271-275.
23. Kimura M, Soemantri A, Ishida T. Malaria species and Southeast Asian ovalocytosis defined by a 27-bp deletion in the erythrocyte band 3 gene. Southeast Asian J Trop Med Public Health. 2002;33:4-6.
24. Miller LH, Hudson D, Rener J, Taylor D, Hadley TJ, Zilberstein D. A monoclonal antibody to rhesus erythrocyte band 3 inhibits invasion by malaria (Plasmodium knowlesi) merozoites. J Clin Invest. 1983;72:1357-1364.
25. Okoye VC, Bennett V. Plasmodium falciparum malaria; band 3 as a possible receptor during invasion of human erythrocytes. Science. 1985;227:169-171.
26. Li X, Chen H, Oo TH, et al. A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. J Biol Chem. 2004;279:5765-5771.
27. Goel VK, Li X, Chen H, Liu SC, Chishti AH, Oh SS. Band 3 is a host receptor binding merpzoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. Proc Natl Acad Sci U S A. 2003;100:5164-5169.
28. Kidson C, Lamont G, Saul A, Nurse GT. Ovalocytic erythrocytes from Melanesiens are resistant to invasion by malaria parasites in culture. Proc Natl Acad Sci U S A. 1981;78:5829-5832.
29. Bruce LJ, Ring SM, Ridgwell K, et al. South-east asian ovalocytic (SAO) erythrocytes have a cold sensitive cation leak: implications for in vitro studies on stored SAO red cells. Biochim Biophys Acta. 1999;1416:258-270.
30. Patel SS, Mehlotra RK, Kastens W, Mgone CS, Kazura JW, Zimmerman PA.The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood. 2001;98:3489-3491.
31. Cranmer SL, Magowan C, Liang J, Coppel RL, Cooke BM. An alternative to serum for cultivation of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1997;91:363-365.
32. Beeson JG, Rogerson SJ, Cooke BM, et al. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat Med. 2000;6:86-90.
33. Anders RF, Brown GV, Edwards A. Characterization of an S antigen synthesized by several isolates of Plasmodium falciparum. Proc Natl Acad Sci U S A. 1983;80:6652-6656.
34. Walliker D, Quakyi IA, Wellems TE, et al. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science. 1987;236:1661-1666.
35. Cortes A, Mellombo M, Mueller I, Benet A, Reeder JC, Anders RF. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. Infect Immun. 2003;71:1416-1426.
36. Aley SB, Sherwood JA, Marsh K, Eidelman O, Howard RJ. Identification of isolate-specific proteins on sorbitol-enriched Plasmodium falciparum infected erythrocytes from Gambian patients. Parasitology. 1986;92:511-525.
37. Tilley L, Nash GB, Jones GL, Sawyer WH. Decreased rotational diffusion of band 3 in Melanesian ovalocytes from Papua, New Guinea. J Membr Biol. 1991;121:59-66.
38. Clough B, Paulilschke M, Nash GB, et al. Mechanism of regulation of malarial invasion by extraerythrocytic ligands. Mot Biochem Parasitol. 1995;69:19-27.
39. Tilley L, Foley M, Anders RF, et al. Rotational dynamics of the integral membrane protein, band 3, as a probe of the membrane events associated with Plasmodium falciparum infections of human erythrocytes. Biochim Biophys Acta. 1990;1025:135-142.
40. Beckmann R, Smythe JS, Anstee DJ, Tanner MJ. Coexpression of band 3 mutants and Rh polypeptides: differential effects of band 3 on the expression of the Rh complex containing D polypeptide and the Rh complex containing CcEe polypeptide. Blood. 2001;97:2496-2505.
41. Gilberger TW, Thompson JK, Triglia T, Good RT, Duraisingh MT, Cowman AF. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol Chem. 2003;278:14480-14486.
42. Lobo CA, Rodriguez M, Reid M, Lustigman S. Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl). Blood. 2003;101:4628-4631.
43. Rayner JC, Vargas-Serrato E, Huber CS, Galinski MR, Barnwell JW. A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J Exp Med. 2001;194:1571-1581.
44. Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science. 1994;264:1941-1944.
45. Duraisingh MT, Triglia T, Ralph SA, et al. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J. 2003;22:1047-1057.
46. Maier AG, Duraisingh MT, Reeder JC, et al. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med. 2003;9:87-92.
47. Dolan SA, Miller LH, Wellems TE. Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest. 1990;86:618-624.